MedTrace Logo

Dexamethasone Tolerability in the Treatment of Acute Asthma in Children

NCT00973687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2015-08-26

No results posted yet for this study

Summary

The purpose of this study is to assess whether smaller volumes of oral dexamethasone result in better tolerability, specifically less vomiting, in pediatric patients during an acute asthma exacerbation.

Conditions

Interventions

DRUG

Ora Sweet

A pharmaceutical suspending vehicle and flavouring agent added to the dexamethasone. All arms received the same amount of dexamethasone based on the child's weight, only in different volumes.

DRUG

Dexamethasone

Sponsors & Collaborators

  • IWK Foundation

    collaborator UNKNOWN

  • IWK Health Centre

    lead OTHER

Principal Investigators

  • Lyn K Sonnenberg, MD · IWK Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2006-04-30
Completion
2006-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973687 on ClinicalTrials.gov